NextGen forges commercial alliance with Paragon

NextGen Sciences announced a commercial alliance with Paragon Bioservices Inc.

CAMBRIDGESHIRE, U.K.—In early January, NextGen Sciences, a provider of gene-to-protein products and services, announced a commercial alliance with Baltimore, Md.-based Paragon Bioservices Inc., a provider of contract research and manufacturing services. The alliance expands the portfolio of both companies with the ability to offer existing and future customers an integrated offering including molecular biology, protein production, proteomics, functional assay development, biomarker discovery and monitoring. Also, this alliance extends NextGen Sciences' commitment to expand its fee-for-service offering in strategic partnerships in addition to adding new capabilities in house such as the protein biomarker monitoring services announced in November 2007.


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Front Cover

Latest Issue  

• Volume 18 • Issue 12 • December 2022/January 2023

December 2022/January 2023

December 2022/January 2023 issue